4828
T. Ohga et al. / Tetrahedron 5712001) 4825±4829
4. Experimental
0.96 'd, 3H, J6.4 Hz), 1.11±2.03 'm, 9H), 2.14±2.98
'm, 9H), 5.15 's, 1H), 6.90±7.67 'm, 10H); 13C NMR
'CDCl3) d 138.3, 138.1, 130.9, 130.6, 128.2, 127.6, 127.3,
125.7, 74.7, 65.9, 43.7, 41.9, 36.0, 26.3, 24.6, 20.8. EI
HRMS C25H35NO 'M1) 365.2721. Found 365.2725.
4.1. Data for compounds
IR spectra were determined using a Shimadzu IR-435 spec-
trophotometer. 1H NMR and 13C NMR spectra were
recorded at 90 and 23 MHz using a JEOL JNM-EX90
spectrometer, respectively. All NMR spectra were taken in
CDCl3 solution with TMS as the internal standard. Mass
spectra were recorded on a JEOL JMS-SX102A mass
spectrometer. Optical rotations were determined on a
Yanagimoto OR-50 polarimeter. The HPLC analysis was
carried out using a DAICEL Chiralcel OB or OD column
'0.46£25 cm2) with a Shimadzu LC-6A. THF was distilled
from sodium benzophenone ketyl. TLC was carried out on
Merck glass plates precoated with silica gel 60F-254
'0.25 mm) and column chromatography was performed
using Merck 23±400 mesh silica gel. Diethylzinc was
purchased from the Aldrich Chemical Co. 'S)-Leucine
ethyl ester hydrochloride, 'S)-valine methyl ester hydro-
chloride, 'S)-phenylalanine methyl ester hydrochloride,
and the other reagents were obtained from Tokyo Kasei
Kogyo Co. or Wako Pure Chemical Ind. Chiral b-amino
alcohols were prepared according to the previously
described procedure for 1a and 1c.7
4.1.3. (S)-3-Methyl-1,1-diphenyl-2-piperidino-1-butanol
25
2a. Yield 34 and 59%: [a]D 186.9 'c 3.71, CHCl3);IR
'neat) 3350, 3050, 3020, 2910, 2840, 1730, 1600, 1490,
1
1445, 995, 745, 695, 615 cm21; H NMR 'CDCl3) d 0.60
'd, 3H, J6.6 Hz), 1.10 'd, 3H, J6.2 Hz), 1.15±1.85
'm,7H), 1.90±2.78 'm,4H), 3.00 'd, 1H, J10.8 Hz), 6.23
's, 1H), 7.12±7.94 'm, 10H); 13C NMR 'CDCl3) d 146.2,
142.9, 128.0, 127.6, 127.5, 126.9, 126.8, 81.8, 78.0, 52.4,
29.2, 27.2, 24.6, 23.5, 23.4. EI HRMS C22H29NO 'M1)
323.2251. Found 323.2257.
4.1.4. (S)-2-Benzyl-4-methyl-1-phenyl-3-piperidino-2-
25
pentanol 2b. Yield 32 and 74%: [a]D 147.6 'c 3.47,
CHCl3);IR 'neat) 3395, 3080, 3060, 3020, 2920, 2840,
1
1735, 1595, 1490, 1450, 1235, 1085, 745, 695 cm21; H
NMR 'CDCl3) d 0.55±1.74 'm, 7H), 1.00 'd, 3H, J
6.0 Hz), 1.26 'd, 3H, J5.4 Hz), 1.83±3.08 'm, 9H), 6.30
'S, 1H), 6.97±7.78 'm, 10H); 13C NMR 'CDCl3) d 139.1,
138.7, 131.0, 127.6, 127.4, 125.8, 125.5, 73.7, 73.5, 51.9,
44.3, 44.2, 28.3, 27.1, 24.6, 23.6, 23.1. EI HRMS C24H33NO
'M1) 351.2564. Found 35.2569.
4.1.1. (S)-8-Methyl-1-phenyl-4-(3-phenylpropyl)-5-piperi-
dino-4-octanol 1d. 'S)-Leucine ethyl ester hydrochloride
'587 mg, 3.0 mmol) was suspended in Et2O '15 ml) and
neutralized with 10% aqueous NaOH solution. The aqueous
solution was separated and extracted with Et2O '3£5 ml)
and the ethereal solution was dried over MgSO4. The solu-
tion of the resulting amino acid ester in THF '1.5 ml) was
slowly added to Ph'CH2)3MgBr that was prepared from Mg
'292 mg, 12 mmol) and Ph'CH2)3Br '1.8 ml, 12 mmol) in
THF '7.2 ml) and the mixture was stirred for 18 h at room
temperature. An aqueous saturated NH4Cl solution was
added to the reaction mixture and the THF solution was
decanted. The aqueous solution was twice washed with
ethyl acetate. After evaporation of the combined organic
solution, the residue was ¯ash chromatographed 'ethyl
acetate/MeOH, 6:1) to give the amino alcohol '352 mg,
33%). To the amino alcohol in acetonitrile '10 ml), 1,5-
diiodopentane '178 ml, 1.2 mmol) and K2CO3 '331 mg,
2.4 mmol) were added and the mixture was re¯uxed for
19 h. After ®ltration of the reaction mixture and evapo-
ration, the residue was dissolved with CH2Cl2 and dried
over MgSO4. The residue was ¯ash chromatographed
'hexane/ethyl acetate, 10:1) to give a colorless oil 1d
4.1.5. (S)-5-Methyl-1-phenyl-3-(2-phenylethyl)-4-pipero-
25
dino-3-hexanol 2c. Yield 47 and 56%: [a]D 114.9 'c
4.37, CHCl3);IR 'neat) 3400, 3080, 3050, 3020, 2930,
2850, 1735, 1600, 1490, 1445, 1385, 1085, 735, 695,
1
630 cm21; H NMR 'CDCl3) d 1.08 'd, 6H, J6.2 Hz),
1.40±3.16 'm, 20H), 5.67 's, 1H), 6.98±7.55 'm, 10H);
13C NMR 'CDCl3) d 143.7, 143.2, 128.4, 128.3, 128.2,
125.5, 125.4, 75.2, 72.7, 52.9, 40.1, 39.8, 30.5, 30.0, 28.3,
27.3, 24.7, 23.9, 22.6. EI HRMS C26H37NO 'M1) 379.2877.
Found 379.2881.
4.1.6. (S)-1,1,3-Triphenyl-2-piperidino-1-propanol 3a.
25
Yield 29 and 69%: [a]D 110.8 'c 7.61, CHCl3);IR
'neat) 3420, 3060, 3020, 2920, 2840, 1725, 1700, 1655,
1
1595, 1490, 1445, 1270, 1150, 1015, 725, 695 cm21; H
NMR 'CDCl3) d 0.98±2.55 'm, 10H), 2.72 'dd, 1H, J
11.6, 14.7 Hz), 3.15 'dd, 1H, J2.4, 14.7 Hz), 3.90 'dd,
1H, J2.5, 11.6 Hz), 6.35 's, 1H), 7.02±7.78 'm, 15H);
13C NMR 'CDCl3) d 145.6, 144.4, 140.2, 128.9, 128.3,
128.0, 127.8, 127.5, 127.2, 127.1, 126.6, 126.1, 77.5, 74.1,
52.9, 34.1, 26.9, 24.2. EI HRMS C26H29NO 'M1) 371.2251.
Found 371.2252.
25
'325 mg, 77%);[ a]D 10.2 'c 4.35, CHCl3);IR 'neat)
3300, 3020, 3000, 2920, 2840, 2800, 1605, 1490, 1450,
1
1160, 1095, 1030, 984, 745, 695 cm21; H NMR 'CDCl3)
4.1.7. (S)-2-Benzyl-1,4-diphenyl-3-piperidino-2-butanol
25
3b. Yield 35 and 70%: mp 101.58C;[ a]D 19.8 'c
d 0.91 'd, 6H, J6.3 Hz), 1.08±2.13 'm, 17H), 2.13±2.94
'm, 9H), 4.38 's, 1H), 6.95±7.48 'm, 10H); 13C NMR
'CDCl3) d 142.7, 128.4, 128.2, 125.5, 74.1, 67.6, 36.6,
36.2, 35.9, 35.5, 27.2, 26.6, 25.2, 24.7, 24.3, 21.3. EI
HRMS C29H43NO 'M1) 421.3347. Found 421.3349.
12.61, CHCl3);IR 'KBr) 3360, 3120, 3090, 3030, 2940,
2840, 1595, 1490, 1450, 1385, 1085, 1030, 748, 740, 720,
1
695 cm21; H NMR 'CDCl3) d 1.02±1.65 'm, 6H), 2.06±
3.08 'm, 11H), 5.05 's, 1H), 6.91±7.60 'm, 15H); 13C NMR
'CDCl3) d 140.0, 139.2, 139.0, 130.9, 130.6, 129.0, 128.0,
127.7, 126.0, 125.9, 74.9, 70.0, 53.2, 44.1, 42.3, 32.2, 27.0,
24.2. EI HR MS C28H33NO 'M1) 431.2462. Found 431.2467.
4.1.2. (S)-2-Benzyl-5-methyl-1-phenyl-3-piperidino-2-
25
hexanol 1b. Yield 33 and 49%: [a]D 131.3 'c 3.77,
CHCl3);IR 'neat) 3280, 3080, 3020, 2920, 2850, 2820,
1605, 1490, 1450, 1390, 1160, 1090, 1030, 980, 740,
4.1.8. (S)-1,5-Diphenyl-3-(2-phenylethyl)-2-piperidino-3-
25
1
695 cm21; H NMR 'CDCl3) d 0.64 'd, 3H, J6.4 Hz),
pentanol 3c. Yield 28 and 61%: [a]D 129.7 'c 1.45,